Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression

Published:2007-06-20 Issue:6 Volume:2 Page:e549
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hardee Matthew E.,Cao Yiting,Fu Ping,Jiang Xiaohong,Zhao Yulin,Rabbani Zahid N.,Vujaskovic Zeljko,Dewhirst Mark W.,Arcasoy Murat O.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Noninvasive visualization of tumors in rodent dorsal skin window chambers.;Q Huang;Nat Biotechnol,1999

2. Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models.;CY Li;J Natl Cancer Inst,2000

3. Incipient angiogenesis.;J Folkman;J Natl Cancer Inst,2000

4. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation.;Y Cao;Cancer Res,2005

5. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.;S Shan;Faseb J,2004

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Stress Erythropoiesis Pathways in Cancer;Frontiers in Physiology;2022-05-25

2. Recombinant human erythropoietin accelerated the proliferation of non‐small cell lung cancer cell lines and reduced the expression of VEGF, HIF‐1α, and PD‐L1 under a simulated hypoxic environment in vitro;Chronic Diseases and Translational Medicine;2022-03-31

3. Endothelial cell in embryology and organogenesis;The Vascular Endothelium;2022

4. Peptides from Natural or Rationally Designed Sources Can Be Used in Overweight, Obesity, and Type 2 Diabetes Therapies;Molecules;2020-02-29

5. The intensification of anticancer activity of LFM-A13 by erythropoietin as a possible option for inhibition of breast cancer;Journal of Enzyme Inhibition and Medicinal Chemistry;2020-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3